ReviewProstate cancer and prostatic diseases2020
"TREXIT 2020": why the time to abandon transrectal prostate biopsy starts now.
2 registry-linked trialsAbstract readReview
In one paragraph
Review in Prostate cancer and prostatic diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 52 papers, 5 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 5 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Randomized Controlled Trial Comparing Magnetic Resonance Imaging (MRI)-Targeted Biopsy and Extended Transperineal Systematic Biopsy for Detection of Clinically Significant Prostate Cancer: the SMART Trial
Prospective Randomized Controlled Study: Free-Hand Transperineal vs. Transrectal Systematic and Image Fusion Targeted Biopsies Under Local Anesthesia Comparing Rate of Significant Cancer Detection and Complication Rates
Who cites it
52 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- Transrectal vs transperineal prostate biopsy: a systematic review and meta-analysis.BJU international · 2026Pooled it
- Low-dose-rate brachytherapy as a primary treatment for localised and locally advanced prostate cancer: a systematic review of economic evaluations.Prostate cancer and prostatic diseases · 2025Pooled it
- Comparison of Urinary Tract Infection Rates Between Transperineal Prostate Biopsies with and Without Prophylactic Antibiotics: An Updated Systematic Review and Meta-Analysis.Medicina (Kaunas, Lithuania) · 2025Pooled it
- [Prostate biopsy-infection prophylaxis and patient preparation].Urologie (Heidelberg, Germany) · 2023Pooled it
- [Infectious complications following prostate biopsy-Major changes 2020].Der Urologe. Ausg. A · 2020Pooled it
- [Complications after transrectal and transperineal prostate biopsy-results of the first randomized controlled trial: ProBE-PC].Urologie (Heidelberg, Germany) · 2024Trial
- Effect of Anesthesia Type on Clinically Significant Prostate Cancer Detection in Transperineal MRI-Targeted Biopsy.Cancers · 2026Article
- Comparison of Infectious Complications After Transrectal Prostate Biopsy Under Two Antibiotic Prophylaxis Regimens: Ceftriaxone Plus Cefixime Versus Ciprofloxacin Plus Gentamicin.International journal of urology : official journal of the Japanese Urological Association · 2026Article
- Article
- Article
- [Efficiency and safety of transperineal prostate biopsy with a single access point].Revista medica del Instituto Mexicano del Seguro Social · 2026Observational
- Freehand transperineal prostate biopsy under local anesthesia using a novel needle guide system with angle-adjustment feature.The Canadian journal of urology · 2025Article
- Patient satisfaction rates and tolerance of free-hand ultrasound-guided transperineal prostate biopsy in an outpatient setting.Abdominal radiology (New York) · 2025Article
- Patient-reported outcome measures for pain and tolerability of transperineal prostate biopsy under local anaesthesia using the PrecisionPoint™ transperineal access system: A prospective study for a real-world patient experience.Investigative and clinical urology · 2025Article
- Efficacy of Prostate Biopsies via Transperineal and Transrectal Routes for Significant Prostate Cancer Detection: A Multicenter Paired-Matched Study.Diagnostics (Basel, Switzerland) · 2025Article
- Minimizing infectious complications following transrectal prostate biopsy: a proposal for a risk-adapted antibiotic treatment strategy with Ceftriaxone and Ertapenem as key components.World journal of urology · 2024Article
- Evaluating the Role of Ultrasound in Prostate Cancer trial - phase 1: Early experience of micro-ultrasound in the United Kingdom.Ultrasound (Leeds, England) · 2024Article
- TRexit is going one step further.Prostate cancer and prostatic diseases · 2024Article
- Management of Patients With a Negative Multiparametric Prostate MRI Examination:AJR. American journal of roentgenology · 2024Review
- Infectious complications of transrectal prostate biopsy in patients receiving targeted antibiotic prophylaxis after urethral and rectal swab versus standard prophylaxis: A prospective comparative study.Prostate international · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Jeremy GrummetDepartment of Surgery, Central Clinical School, Monash University, Melbourne, VIC, Australia. jpgrummet@gmail.com.ORCID http://orcid.org/0000-0003-4382-8169
Michael A GorinDepartment of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Rick PopertGuy's and St Thomas' Hospital, London, UK.
Tim O'BrienGuy's and St Thomas' Hospital, London, UK.
Alastair D LambOxford University, Oxford, UK.
Boris HadaschikEssen University Hospital, Essen, Germany.
Jan Philipp RadtkeEssen University Hospital, Essen, Germany.
Florian WagenlehnerJustus-Liebig University, Gießen, Germany.
Eduard BacoOslo University Hospital, Oslo, Norway.
Caroline M MooreUniversity College London, London, UK.
Mark EmbertonUniversity College London, London, UK.ORCID http://orcid.org/0000-0003-4230-0338
Arvin K GeorgeUniversity of Michigan, Ann Arbor, MI, USA.
John W DavisMD Anderson Cancer Center, Houston, TX, USA.
Richard J SzaboSouthern California Kaiser Permanente, Los Angeles, CA, USA.
Roger BuckleyNorth York General Hospital, North York, ON, Canada.
Andrew LoblawOdette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.ORCID http://orcid.org/0000-0002-4883-1781
Matthew AllawayUrology Associates, Baltimore, MD, USA.
Christof KastnerAddenbrookes Hospital, Cambridge University, Cambridge, UK.
Erik BriersEuropean Cancer Patient Coalition, Brussels, Belgium.
Peter L RoyceDepartment of Surgery, Central Clinical School, Monash University, Melbourne, VIC, Australia.
Mark FrydenbergMonash University, Clayton, VIC, Australia.
Declan G MurphyPeter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia.
Henry H WooSydney Adventist Hospital, University of Sydney, Sydney, NSW, Australia.
Funding
Cancer Research UK 25812
Abstract
PubMed holds no abstract for this paper.
Indexed as
BiopsyHumansMaleProstateProstatic NeoplasmsRectum
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
NCT04685928ClinicalTrials.gov
NCT04797078ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.